Franklin Resources’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.1B | Buy |
2,722,071
+162,067
| +6% | +$124M | 0.52% | 42 |
|
|
2025
Q4 | $1.98B | Buy |
2,560,004
+106,861
| +4% | +$72.6M | 0.48% | 39 |
|
|
2025
Q3 | $1.38B | Buy |
2,453,143
+139,647
| +6% | +$79M | 0.34% | 64 |
|
|
2025
Q2 | $1.21B | Buy |
2,313,496
+36,821
| +2% | +$20.6M | 0.32% | 74 |
|
|
2025
Q1 | $1.44B | Buy |
2,276,675
+231,465
| +11% | +$159M | 0.42% | 52 |
|
|
2024
Q4 | $1.46B | Buy |
2,045,210
+149,124
| +8% | +$125M | 0.4% | 52 |
|
|
2024
Q3 | $1.91B | Sell |
1,896,086
-27,016
| -1% | -$30.1M | 0.54% | 36 |
|
|
2024
Q2 | $2.02B | Buy |
1,923,102
+228,804
| +14% | +$222M | 0.62% | 27 |
|
|
2024
Q1 | $1.63B | Buy |
1,694,298
+1,210,185
| +250% | +$1.15B | 0.52% | 38 |
|
|
2023
Q4 | $425M | Buy |
484,113
+903
| +0.2% | +$744K | 0.2% | 134 |
|
|
2023
Q3 | $398M | Sell |
483,210
-5,454
| -1% | -$4.29M | 0.2% | 122 |
|
|
2023
Q2 | $351M | Sell |
488,664
-1,120
| -0.2% | -$864K | 0.17% | 153 |
|
|
2023
Q1 | $402M | Sell |
489,784
-13,689
| -3% | -$10.3M | 0.2% | 128 |
|
|
2022
Q4 | $363M | Sell |
503,473
-22,724
| -4% | -$16.8M | 0.19% | 142 |
|
|
2022
Q3 | $362M | Buy |
526,197
+1,511
| +0.3% | +$951K | 0.2% | 135 |
|
|
2022
Q2 | $310M | Sell |
524,686
-39,074
| -7% | -$25.4M | 0.15% | 168 |
|
|
2022
Q1 | $394M | Sell |
563,760
-68,688
| -11% | -$43.5M | 0.16% | 163 |
|
|
2021
Q4 | $399M | Buy |
632,448
+26,801
| +4% | +$16.5M | 0.14% | 181 |
|
|
2021
Q3 | $367M | Sell |
605,647
-7,138
| -1% | -$4.43M | 0.14% | 192 |
|
|
2021
Q2 | $342M | Buy |
612,785
+22,781
| +4% | +$11.5M | 0.13% | 199 |
|
|
2021
Q1 | $279M | Sell |
590,004
-26,184
| -4% | -$12.7M | 0.11% | 218 |
|
|
2020
Q4 | $298M | Sell |
616,188
-104,349
| -14% | -$56.3M | 0.13% | 198 |
|
|
2020
Q3 | $403M | Buy |
720,537
+26,793
| +4% | +$16.2M | 0.2% | 136 |
|
|
2020
Q2 | $442M | Buy |
693,744
+110,879
| +19% | +$62.9M | 0.23% | 117 |
|
|
2020
Q1 | $285M | Sell |
582,865
-76,316
| -12% | -$31.5M | 0.19% | 144 |
|
|
2019
Q4 | $248M | Sell |
659,181
-42,834
| -6% | -$14.4M | 0.13% | 197 |
|
|
2019
Q3 | $195M | Buy |
702,015
+20,208
| +3% | +$5.98M | 0.11% | 234 |
|
|
2019
Q2 | $213M | Buy |
681,807
+112,147
| +20% | +$37.3M | 0.11% | 218 |
|
|
2019
Q1 | $234M | Sell |
569,660
-10,047
| -2% | -$4.14M | 0.13% | 212 |
|
|
2018
Q4 | $217M | Sell |
579,707
-73,178
| -11% | -$26.8M | 0.13% | 203 |
|
|
2018
Q3 | $264M | Sell |
652,885
-37,070
| -5% | -$14.1M | 0.13% | 203 |
|
|
2018
Q2 | $238M | Sell |
689,955
-77,905
| -10% | -$24.4M | 0.12% | 206 |
|
|
2018
Q1 | $264M | Sell |
767,860
-51,936
| -6% | -$18.1M | 0.13% | 195 |
|
|
2017
Q4 | $308M | Buy |
819,796
+35,123
| +4% | +$14.2M | 0.15% | 183 |
|
|
2017
Q3 | $351M | Buy |
784,673
+8,415
| +1% | +$4M | 0.17% | 159 |
|
|
2017
Q2 | $381M | Sell |
776,258
-36,696
| -5% | -$16.1M | 0.19% | 143 |
|
|
2017
Q1 | $315M | Sell |
812,954
-98,673
| -11% | -$36.6M | 0.16% | 169 |
|
|
2016
Q4 | $335M | Buy |
911,627
+127,891
| +16% | +$48.6M | 0.17% | 149 |
|
|
2016
Q3 | $315M | Buy |
783,736
+20,901
| +3% | +$8.38M | 0.16% | 164 |
|
|
2016
Q2 | $266M | Buy |
762,835
+95,552
| +14% | +$36.8M | 0.14% | 179 |
|
|
2016
Q1 | $241M | Buy |
667,283
+30,562
| +5% | +$12.6M | 0.13% | 200 |
|
|
2015
Q4 | $346M | Buy |
636,721
+37,168
| +6% | +$20.1M | 0.18% | 148 |
|
|
2015
Q3 | $279M | Sell |
599,553
-7,515
| -1% | -$4.04M | 0.14% | 171 |
|
|
2015
Q2 | $310M | Buy |
607,068
+17,886
| +3% | +$8.73M | 0.14% | 171 |
|
|
2015
Q1 | $266M | Sell |
589,182
-14,268
| -2% | -$6.05M | 0.12% | 194 |
|
|
2014
Q4 | $248M | Buy |
603,450
+58,632
| +11% | +$23.1M | 0.11% | 201 |
|
|
2014
Q3 | $196M | Sell |
544,818
-304,919
| -36% | -$102M | 0.09% | 230 |
|
|
2014
Q2 | $240M | Sell |
849,737
-266,374
| -24% | -$78.9M | 0.11% | 214 |
|
|
2014
Q1 | $335M | Buy |
1,116,111
+601,619
| +117% | +$185M | 0.16% | 154 |
|
|
2013
Q4 | $142M | Buy |
514,492
+149,155
| +41% | +$42.9M | 0.07% | 290 |
|
|
2013
Q3 | $114M | Buy |
365,337
+192,763
| +112% | +$50.7M | 0.06% | 316 |
|
|
2013
Q2 | $38.8M | Buy |
+172,574
| New | +$40.2M | 0.02% | 585 |
|
Other funds holding REGN
VCM
N
Franklin Resources's REGN Position: Q1 2026 in Review
Franklin Resources increased its Regeneron Pharmaceuticals (REGN) stake by 6.3% in Q1 2026, buying an estimated $124M and bringing the position to 2,722,071 shares worth $2.1B. The position accounts for 0.52% of the portfolio, ranked #42.
Franklin Resources first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Franklin Resources held 2,722,071 shares of Regeneron Pharmaceuticals worth $2.1B as of Q1 2026.
- Franklin Resources bought 162,067 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $124M.
- Regeneron Pharmaceuticals made up 0.52% of Franklin Resources's portfolio in Q1 2026, its #42 holding.
- Franklin Resources first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.